Idiopathic thrombocytopenic purpura natural history, complications and prognosis
|
Idiopathic thrombocytopenic purpura Microchapters |
|
Differentiating Idiopathic thrombocytopenic purpura from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Idiopathic thrombocytopenic purpura natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Idiopathic thrombocytopenic purpura natural history, complications and prognosis |
|
FDA on Idiopathic thrombocytopenic purpura natural history, complications and prognosis |
|
CDC on Idiopathic thrombocytopenic purpura natural history, complications and prognosis |
|
Idiopathic thrombocytopenic purpura natural history, complications and prognosis in the news |
|
Blogs on Idiopathic thrombocytopenic purpura natural history, complications and prognosis |
|
Directions to Hospitals Treating Idiopathic thrombocytopenic purpura |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Natural History
More than 70% of the cases in children end up in remission within 6 months whether treated or not.[1][2][3] Moreover, a third of the remaining chronic cases remitted during the follow-up observation, and another third ended up with only mild thrombocytopenia (>50,000 platelets per μL).[1].
Complications
Subarachnoid, intracerebral hemorrhage or other internal bleeding are very serious possible complications of this disease. Fortunately, these are unlikely in patients with the platelets count above 20,000.
Prognosis
With treatment, the chance of remission (a symptom-free period) is good. Rarely, ITP may become a long-term condition in adults and reappear, even after a symptom-free period.
References
- ↑ 1.0 1.1 Watts RG (2004). "Idiopathic thrombocytopenic purpura: a 10-year natural history study at the children's hospital of alabama". Clinical pediatrics. 43 (8): 691–702. PMID 15494875.
- ↑ Treutiger I, Rajantie J, Zeller B, Henter JI, Elinder G, Rosthøj S (2007). "Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?". Arch. Dis. Child. 92 (8): 704–7. doi:10.1136/adc.2006.098442. PMID 17460024.
- ↑ Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP (2006). "A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur". Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi. 47 (5): 226–31. PMID 17352309.